FdaApplication
NDA 208912
Identifiers
- fda_app_no: NDA208912
Properties
| Property | Value |
|---|---|
| applicant_name | EYEPOINT PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2018-02-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEXYCU KIT | DEXAMETHASONE | 9% | SUSPENSION;INTRAOCULAR |
1 product